A defining feature of multiple sclerosis (MS) is the spatial dissemination of inflammatory demyelinating lesions within the CNS (1) . In some patients, lesion burden is concentrated in the spinal cord with little involvement of the cerebrum (as in the opticospinal form of disease that is more common in Asia, or in a significant cohort of individuals with primary progressive MS) (2) (3) (4) . In others, lesion burden is skewed supratentorially, with little to no involvement of the spinal cord (as in a significant cohort of individuals with relapsing remitting MS in the Western Hemisphere) (5, 6) . The factors that regulate leukocyte trafficking to, and accumulation in, particular regions of the CNS are poorly understood.
Experimental autoimmune encephalomyelitis (EAE), widely used as an animal model of MS, classically manifests as an ascending paralysis that correlates with inflammatory demyelination of the lumbosacral spinal cord (7) . In certain instances, an atypical form of EAE has been observed in which afflicted mice exhibit signs of imbalance/vestibular dysfunction that correlate with lesion formation in the brainstem and/or cerebellar white matter (8) (9) (10) (11) (12) (13) . This clinical phenotype occurs most consistently and prominently under circumstances in which IFN-g bioactivity is suppressed. Hence, IFN-g-and IFN-gR-deficient mice are significantly more likely to develop atypical EAE than their wild-type (WT) counterparts following active immunization (10) . Adoptive transfer experiments have demonstrated that either deficient IFN-g production by encephalitogenic donor T cells or impaired IFN-g signaling into host cells is sufficient for the development of atypical EAE (12) (13) (14) .
In some experimental paradigms, a high incidence of atypical disease has been observed following the transfer of encephalitogenic T cell lines that contain a high ratio of Th17 to Th1 cells. In contrast, conventional disease is mediated by T cell lines that express a low Th17/Th1 ratio (11) . A major function of IL-17, the signature Th17 cytokine, is to induce neutrophil-mobilizing/activating factors, such as G-CSF, and chemokines that target granulocytes, such as CXCL1, CXCL2, and CXCL5 (15) . Conversely, IFN-g skews myeloid cell differentiation in the bone marrow to favor monocytes over granulocytes during immune activation (16) . Therefore, it is not surprising that atypical disease tends to be characterized by neutrophilrich white matter infiltrates, whereas monocytes are more prevalent in the infiltrates of mice with conventional disease (10, 13, 14) . However, a distinctive requirement for neutrophil-mobilizing/ activating factors in atypical EAE versus monocyte-mobilizing factors in conventional EAE has yet to be directly demonstrated.
In the current article, we compared atypical and conventional EAE, induced in IFN-gRKO and WT hosts, respectively, by transfer of the same population of myelin oligodendrocyte (MOG) peptideprimed, IL-12-polarized CD4 + T cells. We found that atypical EAE correlates with preferential upregulation of CXCL2 in the brainstem of IFN-gRKO hosts, and is driven by CXCR2-dependent recruitment of neutrophils to the white matter tracts surrounding the vestibulocochlear nucleus. In WT mice, which have an intact IFN-g signaling pathway, brainstem CXCL2 expression is suppressed and spinal cord CCL2 is upregulated. Consequently, the autoimmune assault is redirected to the spinal cord and manifests as a monocytepredominant infiltrate that is, in part, CCR2 dependent.
Materials and Methods

Mice
Eight-to 14-wk-old CD45.1 congenic and WT C57BL/6 mice were obtained from National Cancer Institute Frederick or The Jackson Laboratory. IFN in the presence of rmIL-12 (6 ng/ml), rmIFN-g (2 ng/ml), and anti-IL-4 mAb (hybridoma 11B11; 10 mg/ml). After 96 h, CD4 T cells were isolated by column separation with CD4 (L3T4) magnetic microbeads, according to the manufacturer's instructions (Miltenyi Biotec). A total of 5 3 10 6 CD4 T cells (85-99% pure) were transferred i.p. into naive hosts. Adoptive transfer recipients were monitored on a daily basis by an examiner who was blinded to experimental groups. Mice were scored for severity of conventional and atypical signs of EAE, using established scales (14, 19) . Specifically, mice with conventional EAE were scored as follows: 0, no abnormality; 1, flaccid tail; 2, waddling gait/difficulty righting from supine position; 3, overt hindlimb weakness; 4, hindlimb paralysis; and 5, forelimb and hindlimb paralysis/moribund. Mice with atypical EAE were scored as follows: 0, no abnormality; 1, slight listing/difficulty righting; 2, obvious imbalance but able to ambulate; 3, severely impaired balance/ambulation; and 4, incapacitated owing to inability to maintain upright posture/spinning.
Histology
After intracardiac perfusion of mice with 13 PBS and 4% paraformaldehyde (PFA), spinal cords and brainstems were removed. The CNS tissues were then fixed in 4% PFA and cut into 50-mm sections on a vibratome (Leica VT1200). Free-floating immunofluorescent staining was performed with primary Abs against MBP 82-87 (1:500) and SMI-32 (1:1000). Goat anti-mouse IgG Alexa Fluor 594 (1:400) and goat anti-rat IgG Alexa Fluor 488 (1:1000) were used as secondary Abs. Sections were incubated with DAPI (100 ng/ml) prior to washing and mounting on slides (Prolong Gold Antifade Reagent, Life Technologies). Fluorescent images were acquired with Nikon Eclipse Ti, CoolSnapEZ camera, and NIS Elements: Basic Research v3.10. Confocal images were acquired using a Nikon A-1 Confocal microscope (Nikon Plan Fluor 103/0.30 or Nikon Plan ApoVC 603/1.40 oil) with diode-based laser system and NIS Elements software. Three-dimensional reconstruction images were generated with Bitplane software (Imaris), using confocal Z-stack images of equal thickness from each group. Appropriate processing, including image overlays and black level and brightness adjustments, was performed in Adobe Photoshop CS5.1 and applied equally to all samples and controls.
CNS inflammatory cell isolation
CNS tissue was harvested and separated into four compartments: spinal cord, brainstem, cerebellum, and cerebrum. Each tissue was homogenized in 1 ml PBS containing a protease inhibitor mixture (Roche) and centrifuged at 800 3 g for 10 min. Supernatants were stored at 280˚C. Tissue pellets were digested with collagenase A (1 mg/ml) and DNase I (1 mg/ml) in HBSS containing calcium and magnesium. Inflammatory cells were isolated over a 27/63% Percoll gradient and counted with a Cellometer AutoT4 automated cell counter (Nexelcom).
Flow cytometry
For surface staining, cells were suspended in PBS with 2% FCS containing Fc Block (50 ng/ml) prior to incubation with fluorochrome-conjugated Abs. For intracellular staining, cells were stimulated with PMA (50 ng/ml) and ionomycin (2 mg/ml) and incubated with brefeldin A (5 mg/ml) for 6-10 h. Cells were then fixed in 4% PFA, permeabilized with 0.5% saponin and incubated with fluorochrome-conjugated anti-cytokine Abs. The stained cells were analyzed with a FACSCanto II flow cytometer using FACSDiva software (v6.1.3, Becton Dickinson). Data were analyzed using FlowJo software (v9.3.2, TreeStar).
Multiplex cytokine analysis
Cytokine levels in homogenate supernatants were measured via a luminex multiplex bead-based assay (Millipore). Data were collected on a Bio-Plex 200 System using the manufacturer's protocols. The data shown indicate levels that fell within the linear portion of a corresponding standard curve. Bradford assays (Thermo Scientific) were performed on tissue homogenates in parallel for normalization to total protein.
Statistical analysis
Statistical analyses were performed using GraphPad Prism software. Twoway ANOVA with a Sidak multiple comparisons test was used to compare disease scores over time. Leukocyte cell numbers and percentages, as well as chemokine and growth factor levels, were compared using the unpaired Student t test. A p value , 0.05 (*) was considered significant, with p , 0.01 (**) and p , 0.001 (***). (Table I, Supplemental Fig. 1 ). Of the remainder, 4 (9%) had pure atypical disease (vestibular signs with no evidence of limb weakness) and 9 (21%) exhibited a mixed phenotype, marked by early signs of atypical disease (i.e., a head tilt) that invariably evolved into ascending paraparesis within 1-2 d. None of the WT mice that presented with conventional disease subsequently developed atypical signs. Conversely, the majority of IFN-gRKO hosts underwent a pure atypical course (24 of 38, or 62%), whereas 4 (11%) exhibited a pure conventional, and 10 (26%) a mixed, disease phenotype.
Results
IFN-gR deficiency in host cells increases the incidence of atypical EAE
Inflammatory demyelination is prominent in the spinal cord of mice with conventional EAE and in the brainstem of mice with atypical EAE CNS tissues were collected from representative adoptive transfer recipients at peak disease, and sections were examined by immunofluorescent staining. We consistently observed inflammatory infiltration, demyelination, and axonopathy of white matter tracts in the spinal cords of WT mice with conventional EAE, but not among IFN-gRKO mice with atypical EAE (Fig. 1A, 1B, left panels) . In contrast, IFN-gRKO mice with atypical EAE displayed pathological changes in white matter surrounding the vestibulocochlear nucleus of the brainstem (Fig. 1A, 1B, right panels) . Inflammation of the vestibulocochlear nerve root has also been highlighted in other models of atypical EAE (9, 12, 20) . Consistent with these observations, significantly more CNS cells were isolated from the spinal cords of WT hosts at the peak of conventional EAE than from the spinal cords of IFN-gRKO hosts at the peak of atypical EAE, whereas the reverse was true with respect to the numbers of inflammatory cells isolated from the brainstem (Fig. 2A) . No significant differences were observed between the two cohorts in the number of inflammatory cells isolated from either the cerebral hemispheres or the cerebella.
The severity of atypical EAE correlates with the number of brainstem neutrophils, whereas the severity of conventional EAE correlates with the number of spinal cord monocytes and donor T cells
We performed a detailed analysis of the cellular composition of leukocytes infiltrating different CNS compartments of IFN-gRKO mice that exclusively exhibited signs of atypical EAE (hereafter referred to as "pure atypical" disease) or of WT mice that exclusively exhibited signs of conventional EAE (hereafter referred to as "pure conventional" disease). Neutrophils constituted a higher percent of total live cells in all CNS compartments of mice with pure atypical EAE when compared with mice with pure conventional EAE (Fig. 2B, left panel) . The absolute number of neutrophils was significantly increased in the brainstem, cerebrum, and cerebellum of mice with pure atypical disease (Fig. 2B, right panel) . In contrast, the percentages and absolute numbers of monocytes/ macrophages and donor T cells were significantly higher in the spinal cords of mice with conventional EAE (Fig. 2C, 2D ). The severity of pure atypical disease directly correlated with the number of neutrophils, but not monocytes/macrophages, infiltrating the brainstem, whereas the severity of pure conventional EAE directly correlated with the number of monocytes/macrophages and donor T cells, but not neutrophils, infiltrating the spinal cord (Fig. 2F, 2G , and data not shown). Collectively, the above data suggest that pure atypical EAE is driven by accumulation of neutrophils in the brainstem, and pure conventional EAE is driven by accumulation of monocytes/macrophages and CD4 + T cells in the spinal cord.
CD4
+ donor T cells traffic to the brainstem and upregulate CD25 and CD69 to a similar extent in WT and IFN-gRKO hosts during the preclinical phase EAE lesion formation is initiated several days prior to clinical onset (21, 22) . The development of CNS infiltrates is contingent upon the passage of myelin epitope-specific effector T cells across the blood-brain barrier or blood-cerebrospinal fluid barrier and their reactivation by local APCs (23) . We questioned whether the distribution of EAE infiltrates in atypical versus conventional EAE reflects differences in trafficking patterns or reactivation of encephalitogenic T cells in the CNS during the preclinical phase. + donor T cells in the brainstem, as well as the spinal cord, of WT compared with IFN-gRKO hosts at the preclinical time point (Fig. 3A, 3B) . A higher percent of CD45 hi CD11b + cells expressed MHC class II in WT versus IFNgRKO CNS infiltrates (Fig. 3C) , demonstrating the presence of immunocompetent APCs in the brainstem of WT hosts. No sig- nificant differences were noted between the groups with respect to the number of CD11b + CD11c + cells in either the brain or spinal cord (data not shown). The percent of CD25 + CD69 + cells (indicative of recently activated cells) within the CD44 + donor T cell population was also comparable between groups (Fig. 3D) . Furthermore, we measured similar quantities of IL-2 protein in CNS tissue homogenates from WT and IFN-gRKO hosts at clinical onset (data not shown). CD45.1 + CD4
+ donor T cells in the brainstem and spinal cord of WT hosts continued to outnumber those cells in IFN-gRKO hosts at peak EAE (Fig. 3A, 3B) . Collectively, these results led us to conclude that the low incidence of atypical EAE in WT mice could not be attributed to impairment in the early migration of encephalitogenic T cells to the brainstem, or in their reactivation once they had infiltrated the brainstem. However, increased accumulation of donor CD4 + T cells in the spinal cord could be, at least in part, responsible for the enhanced susceptibility of WT hosts to conventional EAE.
Neutrophil-attracting chemokines are preferentially upregulated in the brainstem during pure atypical EAE, whereas monocyte-attracting chemokines are preferentially upregulated in the spinal cord during pure conventional EAE We next focused on events downstream of effector T cell homing and reactivation. The development of clinical signs in EAE coincides with CNS infiltration by a secondary wave of circulating leukocytes, in large part composed of myeloid cells (24) . To interrogate the factors that differentially recruit neutrophils to the brainstem of IFN-gRKO hosts, and monocytes to the spinal cord of WT hosts, we collected CNS tissue homogenates from representative mice at clinical onset, and measured levels of candidate chemokines. CXCL2, CCL3, and CCL4 were preferentially expressed in brainstem homogenates of IFN-gRKO hosts, whereas CCL2, CCL5, CXCL9, and CXCL10 were expressed at relatively high levels in spinal cord homogenates of WT hosts (Fig. 4) . Surprisingly, the neutrophil-attracting chemokine CXCL1 was upregulated in the spinal cord and brainstem of WT hosts. The paucity of neutrophils in the CNS infiltrates of WT mice could be secondary to IFN-g-mediated suppression of CXCR2 on neutrophils (25) .
IL-12-polarized T cells mediate atypical EAE in IFN-gRKO hosts via an IL-17-independent pathway
IL-17 is a potent inducer of CXCL2 (15) . In an independent model of EAE induced in the C3H strain, atypical EAE occurs only when Th17 effector cells outnumber Th1 effector cells and is suppressed by IL-17 blockade (11). Although, in our model, donor T cells are polarized with IL-12 and exhibit a classic Th1 profile prior to adoptive transfer (Supplemental Fig. 3) , we entertained the possibility that they upregulate IL-17 themselves, or induce other cell types to produce IL-17, following transfer into IFN-gRKO hosts. Therefore, we measured intracellular cytokine levels in CNSinfiltrating leukocytes from symptomatic WT and IFN-gRKO hosts. A significant percent of transferred CD45.1 + CD4 + donor T cells expressed IFN-g (30-40%) and/or GM-CSF (17-22%), irrespective of the tissue they had accumulated in or of host genotype. Conversely, we detected very few IL-17-expressing donor CD45.1 + CD4 + T cells or host CD45.2 + CD4 + T cells in any of the tissues analyzed (,5%). Consistent with these findings, IFN-g protein was elevated in homogenates of brainstem and spinal cord tissues from WT and IFN-gRKO hosts (620-1200 pg/mg), whereas IL-17 was undetectable or expressed at marginal levels (,5 pg/mg protein). Th2 cytokines (IL-4, IL-5, and IL-13) were also undetectable or at the borderline of detection. To more definitively assess the functional role of IL-17 in our experimental system, we transferred MOG 35-55 -primed, IL-12-polarized donor T cells into IL-17RKO, IFN-gRKO, or IFN-gRKO 3 IL-17RKO mice. The majority of IL-17R single KO mice (63%) developed pure conventional EAE without atypical features (Fig. 5A) . IL-17R/IFN-gR double KO mice exhibited a severity and incidence of atypical EAE similar to that observed in IFN-gRKO mice (Fig. 5A, and data not shown) . Taken together, these experiments demonstrate that, in our experimental paradigm, atypical EAE is IL-17 independent.
CXCR2 blockade abrogates atypical EAE, whereas CCR2 deficiency abrogates conventional EAE On the basis of the chemokine expression patterns shown in Fig. 4 , we hypothesized that CXCL2 plays an instrumental role in the recruitment of neutrophils to the brainstem of IFN-gRKO hosts. However, CCL3 and CCL4 were also induced in the brainstem of IFN-gRKO adoptive transfer recipients (Fig. 4) , potentially providing a default chemokine pathway for leukocyte recruitment should CXCL2 be blocked. Neutrophils are responsive to a broad array of chemoattractants, including formylated peptides and eicosanoids, that could also function in a redundant manner (26) . To directly assess the importance of ELR + CXC chemokines in our experimental system, we treated WT and IFN-gRKO hosts with antisera to CXCR2 (the receptor for CXCL1, CXCL2, and CXCL5) or control sera. Preliminary studies showed that anti-CXCR2 treatment selectively inhibited neutrophil infiltration of the CNS (Supplemental Fig. 4 ). CXCR2 blockade abrogated atypical EAE in IFN-gRKO hosts but did not alter the severity of conventional EAE in WT hosts (Fig. 5B) . A small percentage of WT hosts treated with control sera, but none of the WT hosts treated with anti-CXCR2, exhibited atypical signs (data not shown).
The onset of conventional EAE in WT mice is associated with spinal cord expression of the monocyte-attracting CC chemokine CCL2 (Fig. 4) . In parallel studies, we transferred MOG 35-55 -primed, IL-12-polarized WT or IFN-gKO CD4 + T cells into syngeneic WT or CCR2KO hosts. The severity of conventional EAE was significantly attenuated in CCR2KO compared with WT mice that received WT Th1 cells (Fig. 5C ). Conversely, the low incidence of mice that developed atypical features, and the severity of atypical signs, did not differ significantly between the groups. Of interest, CCR2KO hosts almost exclusively developed atypical EAE following transfer of IFN-gKO Th1 donor cells, whereas WT hosts exhibited a mixture of conventional and atypical features (Fig. 5D) . 
Discussion
Atypical EAE in IFN-gRKO and conventional EAE in WT mice display diametrically different patterns in the spatial distribution of lesions across the neuroaxis. Our data indicate that this is the consequence of distinct CNS region-specific chemokine production following the initial infiltration and reactivation of encephalitogenic T cells. In IFN-gRKO mice, CXCL2 is preferentially upregulated in the brainstem and drives the local accumulation of neutrophils, resulting in atypical EAE. In this issue of The Journal of Immunology, Simmons and colleagues make similar observations in an alternative model of EAE induced by the transfer of IL-23-polarized T cells into C3HeB/FeJ hosts (31) . They found that CXCL2 was upregulated in astrocytes. Its cellular source remains to be identified in our model. Choroid epithelial cells as well as astrocytes are capable of producing ELR + CXC chemokines (27) (28) (29) , which is consistent with the recent observation that IFN-g suppresses atypical EAE via modulation of a nonhematopoietic, radioresistant cell type (10) . If brainstem astrocytes are also the source of CXCL2 in our model, then they might constitute a distinct subset not found in the spinal cord. More definitive conclusions await experiments with IFN-gR conditional knockout mice. The factors that induce CXCL2 in the brainstem of C57BL/6 IFN-gRKO hosts are also unknown. IL-17 was a logical candidate because it stimulates the production of neutrophil-attracting chemokines in a wide variety of cells (15) and has been implicated in alternative models of atypical EAE (11, 14) . However, our data demonstrate that atypical EAE induced by the transfer of MOG 35-55 -primed, Th1-polarized WT cells into IFNgRKO hosts is IL-17 independent (Fig. 5) . Other candidates include IL-1, TNF-a, and GM-CSF, although the levels of those molecules were similar in brainstem and spinal cord homogenates from mice with atypical EAE, and were lower than their respective levels in homogenates from mice with conventional EAE (data not shown).
In WT hosts, CCL2 is upregulated in both the spinal cord and brainstem, but only facilitates parenchymal infiltration of the spinal cord. Donor T cells and monocytes appear to initially cross the bloodcerebrospinal fluid barrier at the level of the fourth ventricle in WT hosts, but fail to penetrate deep into the brainstem distal to the choroid plexus ( Figs. 1 and 2 ). This disparity may be the consequence of paradoxical effects of IFN-g-modulated molecules that regulate leukocyte trafficking when expressed in different locations. For example, CXCL12 facilitates neuroinflammation when expressed on the luminal aspect of the cerebrovasculature, but curtails the migration of leukocytes beyond the perivascular space when translocated to the abluminal side (30) . IFN-g and IL-17 have opposing effects on the internalization of CXCL12 by brain microvessel endothelial cells. We are currently investigating the effects of IFN-g, produced by encephalitogenic T cells, on the expression of adhesion molecules and chemokines by choroid plexus epithelial cells, glia, and cerebrovascular/meningovascular endothelial cells in vivo, and the repercussions for brainstem and spinal cord inflammation.
Lesions are widely distributed throughout the neuroaxis in the majority of MS patients. However, across the spectrum of human demyelinating disease, there exist subpopulations in which inflammatory demyelination is consistently focused in a particular region of the CNS, resulting in distinct clinical phenotypes (2, 3, 5, 6) . Analogous to atypical and conventional EAE, the pattern of inflammation in human disease tends to associate with particular CNS chemokine profiles and leukocyte subsets. Although EAE does not perfectly simulate MS, the current data illustrate, in principle, how site-specific interactions between infiltrating immune cells and CNS resident cells determine clinical and histopathological phenotypes of autoimmune demyelinating disease. Ultimately, the current line of research might lead to the identification of clinical and radiological features that correlate with CNS immune profiles, thereby facilitating clinical management.
